Sentences with phrase «from global funds»

Part of this success is due to President George W. Bush's President's Malaria Initiative, which helped ensure that more than 1 million bed nets were distributed across the country, and leadership from the Global Fund to Fight AIDS, TB and Malaria.

Besides, the panel said, a plan WHO and the six countries of the Greater Mekong launched in 2015 to eliminate P. falciparum malaria by 2025 should halt the spread of resistant strains, and the project just got a $ 242 million boost from the Global Fund to Fight AIDS, Tuberculosis and Malaria.

A widely picked up Associated Press story about fraud committed by several countries that received grants from the Global Fund to Fight AIDS, Tuberculosis, and Malaria has triggered a flurry of reactions.

«Our total payout from the KDP Select Global Fund will be unaffected by the transition to KENPC v3.0, and the amount you earn from the global fund will continue to be determined based on your share of total pages read by Kindle Unlimited (KU) and Kindle Owners» Lending Library (KOLL) customers.

As with Kindle Unlimited, only authors whose eBooks are in the KDP Select program get a share of royalties from the Global Fund for any eBooks Prime members read from the KOLL.

The greatest pro of KDP Select is considered to be Kindle Unlimited: your book is available as part of a subscription program in U.S, U.K., Germany, Italy, Spain, France, Brazil, Mexico, Canada, India, Japan, and Australia, and you'll be paid from a global fund based on how many pages your readers have read.

For example, just over half of the latest round of grants from the Global Fund — which totalled US$ 846 million — will go to fight HIV / AIDS.

Not exact matches

Important factors that could cause actual results to differ materially from those reflected in such forward - looking statements and that should be considered in evaluating our outlook include, but are not limited to, the following: 1) our ability to continue to grow our business and execute our growth strategy, including the timing, execution, and profitability of new and maturing programs; 2) our ability to perform our obligations under our new and maturing commercial, business aircraft, and military development programs, and the related recurring production; 3) our ability to accurately estimate and manage performance, cost, and revenue under our contracts, including our ability to achieve certain cost reductions with respect to the B787 program; 4) margin pressures and the potential for additional forward losses on new and maturing programs; 5) our ability to accommodate, and the cost of accommodating, announced increases in the build rates of certain aircraft; 6) the effect on aircraft demand and build rates of changing customer preferences for business aircraft, including the effect of global economic conditions on the business aircraft market and expanding conflicts or political unrest in the Middle East or Asia; 7) customer cancellations or deferrals as a result of global economic uncertainty or otherwise; 8) the effect of economic conditions in the industries and markets in which we operate in the U.S. and globally and any changes therein, including fluctuations in foreign currency exchange rates; 9) the success and timely execution of key milestones such as the receipt of necessary regulatory approvals, including our ability to obtain in a timely fashion any required regulatory or other third party approvals for the consummation of our announced acquisition of Asco, and customer adherence to their announced schedules; 10) our ability to successfully negotiate, or re-negotiate, future pricing under our supply agreements with Boeing and our other customers; 11) our ability to enter into profitable supply arrangements with additional customers; 12) the ability of all parties to satisfy their performance requirements under existing supply contracts with our two major customers, Boeing and Airbus, and other customers, and the risk of nonpayment by such customers; 13) any adverse impact on Boeing's and Airbus» production of aircraft resulting from cancellations, deferrals, or reduced orders by their customers or from labor disputes, domestic or international hostilities, or acts of terrorism; 14) any adverse impact on the demand for air travel or our operations from the outbreak of diseases or epidemic or pandemic outbreaks; 15) our ability to avoid or recover from cyber-based or other security attacks, information technology failures, or other disruptions; 16) returns on pension plan assets and the impact of future discount rate changes on pension obligations; 17) our ability to borrow additional funds or refinance debt, including our ability to obtain the debt to finance the purchase price for our announced acquisition of Asco on favorable terms or at all; 18) competition from commercial aerospace original equipment manufacturers and other aerostructures suppliers; 19) the effect of governmental laws, such as U.S. export control laws and U.S. and foreign anti-bribery laws such as the Foreign Corrupt Practices Act and the United Kingdom Bribery Act, and environmental laws and agency regulations, both in the U.S. and abroad; 20) the effect of changes in tax law, such as the effect of The Tax Cuts and Jobs Act (the «TCJA») that was enacted on December 22, 2017, and changes to the interpretations of or guidance related thereto, and the Company's ability to accurately calculate and estimate the effect of such changes; 21) any reduction in our credit ratings; 22) our dependence on our suppliers, as well as the cost and availability of raw materials and purchased components; 23) our ability to recruit and retain a critical mass of highly - skilled employees and our relationships with the unions representing many of our employees; 24) spending by the U.S. and other governments on defense; 25) the possibility that our cash flows and our credit facility may not be adequate for our additional capital needs or for payment of interest on, and principal of, our indebtedness; 26) our exposure under our revolving credit facility to higher interest payments should interest rates increase substantially; 27) the effectiveness of any interest rate hedging programs; 28) the effectiveness of our internal control over financial reporting; 29) the outcome or impact of ongoing or future litigation, claims, and regulatory actions; 30) exposure to potential product liability and warranty claims; 31) our ability to effectively assess, manage and integrate acquisitions that we pursue, including our ability to successfully integrate the Asco business and generate synergies and other cost savings; 32) our ability to consummate our announced acquisition of Asco in a timely matter while avoiding any unexpected costs, charges, expenses, adverse changes to business relationships and other business disruptions for ourselves and Asco as a result of the acquisition; 33) our ability to continue selling certain receivables through our supplier financing program; 34) the risks of doing business internationally, including fluctuations in foreign current exchange rates, impositions of tariffs or embargoes, compliance with foreign laws, and domestic and foreign government policies; and 35) our ability to complete the proposed accelerated stock repurchase plan, among other things.

And the amount of money these mutual funds are pouring in is worth noting: «Last year alone, global mutual fund investors poured $ 23.7 billion into 192 VC transactions — the highest amount of capital invested ever and a 66 % increase from the year prior,» states the release.

Mark Cuban continued to contribute to Relativity Space, which also raised funds from Playground Global, Y Combinator Continuity and Social Capital.

• Viela Bio, which spun off from MedImmune, the global biologics research and development arm of AstraZeneca, raised $ 250 million in funding.

Despite the fact that the company launched in the midst of a national economic crisis, it has since reeled in more than $ 45 million in funding from investors such as New York City - based General Atlantic as well as Endeavor Catalyst, an investing branch of the eponymous, global entrepreneurship support network.

A spike in bond yields and a clear change of direction from central banks means there isn't a lot of value in global bond markets, a fund manager told CNBC on Tuesday.

More from Global Investing Hot Spots: 6 global trends that can derail your portfolio in 2018 «Dogs of the World» stock strategy works The Swedes figured out how to launch bitcoinGlobal Investing Hot Spots: 6 global trends that can derail your portfolio in 2018 «Dogs of the World» stock strategy works The Swedes figured out how to launch bitcoinglobal trends that can derail your portfolio in 2018 «Dogs of the World» stock strategy works The Swedes figured out how to launch bitcoin funds

A number of funds bet heavily on an oil rally early in the year, boosting long futures positions to a record in late February, before oil went into a prolonged slump as global supply remained elevated despite cuts from OPEC.

The service's quick adoption and global traction helped it secure a $ 6 million Series A funding round in January from Qualcomm Ventures, Yahoo co-founder Jerry Yang and WebEx co-founder Subrah Iyar.

NEW YORK, Jan 18 - U.S. fund investors pulled $ 3.1 billion from high - yield «junk» bonds during the latest week, Lipper data showed on Thursday, offering new warning signs about risk appetite despite global markets» continuing triumph.

After PayPal: After earning $ 55 million from his 3.7 per cent stake in the eBay deal, Thiel immediately founded hedge fund Clarium Capital, a global macro hedge fund and made the ludicrously savvy decision to angel invest $ 500,000 in fledgling social network Facebook.

The new fund comes after Samsung (ssnlf) changed the name of its startup investment arm from the Samsung Global Innovation Center, and opened a Tel Aviv office in September.

Last year, a team of four students from New York University's Abu Dhabi campus and I presented in front of a panel of judges at the Hult Prize, which awards $ 1 million in seed funding to innovative startup ideas that address a global social challenge.

Global funding for hardware and software to streamline building projects, or to sell and rent construction equipment, rose to $ 254 million in 2015 from $ 51 million in 2010, according to researcher CB Insights — and analysts say it's still an emerging industry.

• Flexport, a San Francisco - based technology platform for global trade, raised $ 100 million in funding from SF Holding.

Additionally, the firm has secured a $ 1.8 million investment from Acumen, a nonprofit global venture fund addressing international poverty.

The new funding comes from a number of investors, including Khosla, UBS, Viking Global Investors, Gates, and Horizons Ventures.

Take government - owned sovereign wealth funds for example: Over $ 5 trillion is invested in global capital markets from SWF's coming directly from oil - producing nations.

Prior to the funding round, Rubin raised $ 30 million (# 23 million) for Essential from Playground Global and Redpoint Ventures, according to Equidate.

DST Global, an investment company created by the Russian billionaire Yuri Milner, funneled hundreds of millions into Facebook and Twitter, but the funds came from two government - controlled financial institutions.

The mobile app followed in August, along with a healthy $ 500,000 chunk of seed funding from Jordan Banks, Facebook's global head of vertical strategy, and other investors in September.

Autonomous NEXT recorded a record high of 226 global hedge funds focused on trading cryptocurrencies, up from 110 global hedge funds as of October 18.

(Reuters)- Blackstone Group LP has secured $ 17 billion from investors for its latest global private equity fund in just seven months, the biggest so - called first close of a buyout fund ever, according to people familiar with the matter.

Two weeks earlier, he had gotten a call from the company's largest shareholder, Texas - based fund manager US Global Investors Inc., warning that a broker at another firm had received an anonymous call, saying Muddy Waters was about to publish a report on Silvercorp and US Global should dump its stock.

In the first quarter of 2016, global VC funding hit $ 25.5 billion, a slight dip from the $ 27.7 billion recorded in the fourth quarter of 2015 and a significant decline from the $ 39 billion invested in the third quarter, according to data from KPMG.

To accomplish this, the new WHO report estimates that global funding for combating the disease will have to increase from the $ 2.7 billion that's spent today to $ 8.7 billion in 2030.

Among the factors that could cause actual results to differ materially are the following: (1) worldwide economic, political, and capital markets conditions and other factors beyond the Company's control, including natural and other disasters or climate change affecting the operations of the Company or its customers and suppliers; (2) the Company's credit ratings and its cost of capital; (3) competitive conditions and customer preferences; (4) foreign currency exchange rates and fluctuations in those rates; (5) the timing and market acceptance of new product offerings; (6) the availability and cost of purchased components, compounds, raw materials and energy (including oil and natural gas and their derivatives) due to shortages, increased demand or supply interruptions (including those caused by natural and other disasters and other events); (7) the impact of acquisitions, strategic alliances, divestitures, and other unusual events resulting from portfolio management actions and other evolving business strategies, and possible organizational restructuring; (8) generating fewer productivity improvements than estimated; (9) unanticipated problems or delays with the phased implementation of a global enterprise resource planning (ERP) system, or security breaches and other disruptions to the Company's information technology infrastructure; (10) financial market risks that may affect the Company's funding obligations under defined benefit pension and postretirement plans; and (11) legal proceedings, including significant developments that could occur in the legal and regulatory proceedings described in the Company's Annual Report on Form 10 - K for the year ended Dec. 31, 2017, and any subsequent quarterly reports on Form 10 - Q (the «Reports»).

The International Monetary Fund welcomed calls from the U.S. that it should push for more transparency in global trade and lending, the Fund's boss said Sunday.

Money from the FFF group represents the largest source of funding for new startups, according to the «Global Entrepreneurship Monitor 2012 United States Report.»

These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).

But the WHO and other global health responders can only follow rules No. 1, 2, and 3, if they have ample funding and active support from the rest of the world.

• Arbour Group, an Oakbrook Terrace, Illinois - based provider of regulatory compliance services for the global life sciences industry, raised funding of an undisclosed amount from Keystone Capital Inc..

And Sequoia is definitely making an enormous leap from a previous $ 2 billion raise for its most recent global growth fund in 2015 that was disclosed in June.

According to sources close to the situation, the high - profile venture capital firm Sequoia Capital is in the early stages of raising a third global growth fund that could range from $ 5 billion to $ 6 billion.

Fidelity Strategic Funds are multi-asset-class strategies that seek to address key income needs — bond income from global sources, non-bond income, and real return — by investing in a diversified mix of fixed income and / or equity investments chosen for their historical combined performance.

When it closes a reported $ 160 million funding round from Index Ventures, Horizons Ventures, Institutional Venture Partners, and DST Global, the company will have a $ 2.8 billion valuation, making it one of the most valuable venture capital - backed businesses in the world.

Funding history: Wish to date has raised over $ 1 billion in venture funding, from firms like Everbright - IDG, Founders Fund, GGV Capital, GST Global, Temasek, Third Point Ventures and FormaFunding history: Wish to date has raised over $ 1 billion in venture funding, from firms like Everbright - IDG, Founders Fund, GGV Capital, GST Global, Temasek, Third Point Ventures and Formafunding, from firms like Everbright - IDG, Founders Fund, GGV Capital, GST Global, Temasek, Third Point Ventures and Formation 8.

The new funding, led by Goldman Sachs and Princeville Global (with participation from existing investors, including Venrock, Shasta Ventures and Tenaya Capital), will be used to continue the company's rapid expansion in the U.S. and abroad — and brings the company's total financing to $ 160 million.

Online home rental marketplace Airbnb Inc is said to be raising $ 1.5 billion in a fund raising round led by U.S. private equity firm General Atlantic with participation from Hillhouse Capital, Tiger Global and others.

The mechanism spares the cash - strapped, understaffed agency from having to fund efforts to monitor these multibillion dollar global enterprises.

Over a 12 - month period (ended June 30, 2017), global hedge funds, as measured by the HFRX Global Hedge Fund Index, delivered decent gains of 6.0 % in US dollar terms.1 That's a vast improvement in the performance of these alternative investments from the prior two global hedge funds, as measured by the HFRX Global Hedge Fund Index, delivered decent gains of 6.0 % in US dollar terms.1 That's a vast improvement in the performance of these alternative investments from the prior two Global Hedge Fund Index, delivered decent gains of 6.0 % in US dollar terms.1 That's a vast improvement in the performance of these alternative investments from the prior two years.

Myriota's investment of $ 1.36 million, which will be matched by a grant from the South Australian State Government's Future Jobs Fund, will allow the company to integrate its ultra-low-cost satellite IoT solution into a wide range of global products and services.

In addition to these traditional competitors within the global alternative asset management industry, we have increasingly faced competition from local and regional firms, financial institutions and sovereign wealth funds, in the various countries in which we invest.